Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Windlas Biotech Limited (NSE: WINDLAS), ISIN INE0H5O01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
WINDLAS last traded at ₹1079.90 (+0.23%), with a 52-week range of ₹699.35 to ₹1181.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 63.31%, FIIs 2.04%, DIIs 9.84%, mutual funds 5.76%.
EquiSense Score (ECS): 83/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.